2/10
07:00 am
stro
Sutro Biopharma Announces Pricing of $110.0 million Underwritten Offering
Medium
Report
Sutro Biopharma Announces Pricing of $110.0 million Underwritten Offering
2/10
06:03 am
stro
Sutro Biopharma, Inc. (NASDAQ:STRO) has caught the attention of institutional investors who hold a sizeable 41% stake [Yahoo! Finance]
Medium
Report
Sutro Biopharma, Inc. (NASDAQ:STRO) has caught the attention of institutional investors who hold a sizeable 41% stake [Yahoo! Finance]
1/20
08:03 am
stro
Sutro Biopharma (NASDAQ:STRO) was upgraded by analysts at Citizens Jmp from a "market perform" rating to a "market outperform" rating. They now have a $23.00 price target on the stock.
Medium
Report
Sutro Biopharma (NASDAQ:STRO) was upgraded by analysts at Citizens Jmp from a "market perform" rating to a "market outperform" rating. They now have a $23.00 price target on the stock.
1/20
06:01 am
stro
Sutro Biopharma (NASDAQ:STRO) was upgraded by analysts at Citigroup Inc. to an "outperform" rating.
Medium
Report
Sutro Biopharma (NASDAQ:STRO) was upgraded by analysts at Citigroup Inc. to an "outperform" rating.
1/7
04:05 pm
stro
Sutro Biopharma to Present at the 44th Annual J.P. Morgan Healthcare Conference
Neutral
Report
Sutro Biopharma to Present at the 44th Annual J.P. Morgan Healthcare Conference
12/31
06:12 am
stro
Sutro Biopharma (NASDAQ:STRO) Will Have To Spend Its Cash Wisely [Yahoo! Finance]
Medium
Report
Sutro Biopharma (NASDAQ:STRO) Will Have To Spend Its Cash Wisely [Yahoo! Finance]
12/23
07:56 am
stro
Ipsen outlays $1bn for China-based Simcere's preclinical ADC [Yahoo! Finance]
Low
Report
Ipsen outlays $1bn for China-based Simcere's preclinical ADC [Yahoo! Finance]
12/22
08:02 am
stro
Sutro Biopharma (NASDAQ:STRO) had its price target raised by analysts at HC Wainwright from $2.00 to $10.00. They now have a "neutral" rating on the stock.
Medium
Report
Sutro Biopharma (NASDAQ:STRO) had its price target raised by analysts at HC Wainwright from $2.00 to $10.00. They now have a "neutral" rating on the stock.
12/17
04:05 pm
stro
Sutro Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
Low
Report
Sutro Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
12/17
09:06 am
stro
Sutro Biopharma (NASDAQ:STRO) had its "buy" rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft.
Medium
Report
Sutro Biopharma (NASDAQ:STRO) had its "buy" rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft.
12/16
04:05 pm
stro
Sutro Biopharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Sutro Biopharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12/1
08:52 am
stro
Sutro Biopharma Announces 1-for-10 Reverse Stock Split [Yahoo! Finance]
Medium
Report
Sutro Biopharma Announces 1-for-10 Reverse Stock Split [Yahoo! Finance]
12/1
08:00 am
stro
Sutro Biopharma Announces 1-for-10 Reverse Stock Split
High
Report
Sutro Biopharma Announces 1-for-10 Reverse Stock Split
11/26
02:19 pm
stro
Sutro Biopharma (NASDAQ:STRO) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Sutro Biopharma (NASDAQ:STRO) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
11/12
11:04 am
stro
Sutro Biopharma Highlights Next-Generation ADC Innovation at Virtual R&D Day [Yahoo! Finance]
Low
Report
Sutro Biopharma Highlights Next-Generation ADC Innovation at Virtual R&D Day [Yahoo! Finance]
11/12
10:00 am
stro
Sutro Biopharma Highlights Next-Generation ADC Innovation at Virtual R&D Day
Low
Report
Sutro Biopharma Highlights Next-Generation ADC Innovation at Virtual R&D Day